Acquisition - Narrative (Details) $ / shares in Units, $ in Thousands			1 Months Ended					3 Months Ended			12 Months Ended
	Aug. 04, 2021 USD ($) $ / shares shares	May 24, 2021 days	Aug. 31, 2023 shares	Jun. 30, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares	Aug. 31, 2022 shares	Aug. 31, 2021 shares	Sep. 30, 2023 shares	Sep. 30, 2022 shares	Sep. 30, 2021 shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Business Acquisition [Line Items]
Share price (in usd per share) | $ / shares				$ 21.10	$ 18.50
Research and Development Asset Acquired Other than through Business Combination, Writeoff, Statement of Income or Comprehensive Income [Extensible Enumeration]											Research and development
Cash paid in acquisition											$ 0	$ 0	$ 6,704
Consecutive trading day period (in days) | days		45
Adrestia Therapeutics Ltd
Business Acquisition [Line Items]
Shares issued in asset acquisition (in shares) | shares				3,430,867
Asset acquisition, consideration transferred				$ 72,400
Contingent payment, value				$ 326,500
IPR&D expense											76,500
Vertuis Bio, Inc.
Business Acquisition [Line Items]
Shares issued in asset acquisition (in shares) | shares					500,000
Asset acquisition, consideration transferred											10,250
Contingent payment, value					$ 1,000
IPR&D expense											$ 10,300
Vertuis Bio, Inc. | Milestone Event 1
Business Acquisition [Line Items]
Contingent payment, value					1,000
Vertuis Bio, Inc. | Milestone Event 2
Business Acquisition [Line Items]
Contingent payment, value					23,000
Vertuis Bio, Inc. | Milestone Event 3
Business Acquisition [Line Items]
Contingent payment, value					$ 63,800
Motus Biosciences, Inc. and AlgaeneX, Inc.
Business Acquisition [Line Items]
Cash paid in acquisition	$ 10,500
Acquisition related expenses													$ 600
Motus Biosciences, Inc.
Business Acquisition [Line Items]
Shares issued in acquisition (in shares) | shares	2,889,367		177,203			171,427	171,427	177,203	171,427	2,889,367
Shares issued upon milestone achievements (in shares) | shares	5,348,572						5,348,572
Cash to be paid upon achievement of milestones	$ 35,000
Share price used to calculate issuable shares (in dollars per share) | $ / shares	$ 27.11
Motus Biosciences, Inc. | First anniversary of closing date
Business Acquisition [Line Items]
Shares issued in acquisition (in shares) | shares	184,433						184,433
Motus Biosciences, Inc. | Second anniversary of closing date
Business Acquisition [Line Items]
Shares issued in acquisition (in shares) | shares	184,433						184,433
Motus Biosciences, Inc. | Third anniversary of closing date
Business Acquisition [Line Items]
Shares issued in acquisition (in shares) | shares	184,433						184,433
AlgaeneX, Inc.
Business Acquisition [Line Items]
Shares issued upon milestone achievements (in shares) | shares	368,867
Cash paid in acquisition	$ 1,500
Share price used to calculate issuable shares (in dollars per share) | $ / shares	$ 27.11